<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39411394</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1078-4497</ISSN><JournalIssue CitedMedium="Print"><Volume>41</Volume><Issue>Suppl 3</Issue><PubDate><Year>2024</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Federal practitioner : for the health care professionals of the VA, DoD, and PHS</Title><ISOAbbreviation>Fed Pract</ISOAbbreviation></Journal><ArticleTitle>Improving Colorectal Cancer Screening via Mailed Fecal Immunochemical Testing in a Veterans Affairs Health System.</ArticleTitle><Pagination><StartPage>S39</StartPage><EndPage>S42</EndPage><MedlinePgn>S39-S42</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.12788/fp.0496</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Colorectal cancer screening rates at the Veterans Affairs Connecticut Healthcare System (VACHS) decreased during the COVID-19 pandemic. Fecal immunochemical testing is recognized as a tier 1 preferred screening method by the US Multi-Society Task Force on Colorectal Cancer. The VACHS implemented a program that mailed fecal immunochemical testing kits to patients to improve colorectal cancer screening rates.</AbstractText><AbstractText Label="OBSERVATIONS" NlmCategory="UNASSIGNED">This article describes the components of the VACHS patient aligned care team-based mailed fecal immunochemical testing program. Fecal immunochemical testing utilization, completion, and colorectal cancer screening rates at VACHS substantially increased after the implementation of this project.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Through a proactive, population-based colorectal cancer screening program centered on mailed fecal immunochemical testing kits outside of a traditional patient visit, VACHS substantially increased the utilization of fecal immunochemical testing kits as well as colorectal cancer screening rates.</AbstractText><CopyrightInformation>Copyright © 2024 Frontline Medical Communications Inc., Parsippany, NJ, USA.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Jin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Veterans Affairs Connecticut Healthcare System, West Haven.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Yale University School of Medicine, New Haven, Connecticut.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kravetz</LastName><ForeName>Jeffrey</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Veterans Affairs Connecticut Healthcare System, West Haven.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Yale University School of Medicine, New Haven, Connecticut.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spelman</LastName><ForeName>Juliette</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Veterans Affairs Connecticut Healthcare System, West Haven.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Yale University School of Medicine, New Haven, Connecticut.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roy</LastName><ForeName>Kimberley</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Veterans Affairs Connecticut Healthcare System, West Haven.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lilly</LastName><ForeName>Vincent</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Veterans Affairs Connecticut Healthcare System, West Haven.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cosentino</LastName><ForeName>Danielle</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Veterans Affairs Connecticut Healthcare System, West Haven.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruser</LastName><ForeName>Christopher</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Veterans Affairs Connecticut Healthcare System, West Haven.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Yale University School of Medicine, New Haven, Connecticut.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Fed Pract</MedlineTA><NlmUniqueID>9500574</NlmUniqueID><ISSNLinking>1078-4497</ISSNLinking></MedlineJournalInfo><CoiStatement>Author disclosures: The authors report no actual or potential conflicts of interest or outside sources of funding with regard to this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>10</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>10</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>4</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39411394</ArticleId><ArticleId IdType="pmc">PMC11473113</ArticleId><ArticleId IdType="doi">10.12788/fp.0496</ArticleId><ArticleId IdType="pii">fp-41-08s-s39</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>American Cancer Society. Key statistics for colorectal cancer.  [Accessed June 11, 2024].  Revised January 29, 2024. 
 https://www.cancer.org/cancer/types/colon-rectal-cancer/about/key-statistics.html
.</Citation></Reference><Reference><Citation>Chen RC, Haynes K, Du S, Barron J, Katz AJ. Association of cancer screening deficit in the United States with the COVID-19 pandemic. JAMA Oncol. 2021;7(6):878–884. doi: 10.1001/jamaoncol.2021.0884.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaoncol.2021.0884</ArticleId><ArticleId IdType="pmc">PMC8085759</ArticleId><ArticleId IdType="pubmed">33914015</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazidimoradi A, Tiznobaik A, Salehiniya H. Impact of the COVID-19 pandemic on colorectal cancer screening: a systematic review. J Gastrointest Cancer. 2022;53(3):730–744. doi: 10.1007/s12029-021-00679-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12029-021-00679-x</ArticleId><ArticleId IdType="pmc">PMC8371036</ArticleId><ArticleId IdType="pubmed">34406626</ArticleId></ArticleIdList></Reference><Reference><Citation>Adams MA, Kurlander JE, Gao Y, Yankey N, Saini SD. Impact of coronavirus disease 2019 on screening colonoscopy utilization in a large integrated health system. Gastroenterology. 2022;162(7)(e2):2098–2100. doi: 10.1053/j.gastro.2022.02.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2022.02.034</ArticleId><ArticleId IdType="pmc">PMC8867975</ArticleId><ArticleId IdType="pubmed">35219698</ArticleId></ArticleIdList></Reference><Reference><Citation>Sundaram S, Olson S, Sharma P, Rajendra S. A review of the impact of the COVID-19 pandemic on colorectal cancer screening: implications and solutions. Pathogens. 2021;10(11):558. doi: 10.3390/pathogens10111508.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens10111508</ArticleId><ArticleId IdType="pmc">PMC8619517</ArticleId><ArticleId IdType="pubmed">34832663</ArticleId></ArticleIdList></Reference><Reference><Citation>US Preventive Services Task Force. Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. JAMA. 2021;325(19):1965–1977. doi: 10.1001/jama.2021.6238.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.6238</ArticleId><ArticleId IdType="pubmed">34003218</ArticleId></ArticleIdList></Reference><Reference><Citation>Robertson DJ, Lee JK, Boland CR, et al. Recommendations on fecal immunochemical testing to screen for colorectal neoplasia: a consensus statement by the US Multi-Society Task Force on Colorectal Cancer. Gastrointest Endosc. 2017;85(1)(e3):2–21. doi: 10.1016/j.gie.2016.09.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gie.2016.09.025</ArticleId><ArticleId IdType="pubmed">27769516</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JK, Liles EG, Bent S, Levin TR, Corley DA. Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysis. Ann Intern Med. 2014;160(3):171. doi: 10.7326/M13-1484.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M13-1484</ArticleId><ArticleId IdType="pmc">PMC4189821</ArticleId><ArticleId IdType="pubmed">24658694</ArticleId></ArticleIdList></Reference><Reference><Citation>Rex DK, Boland CR, Dominitz JA, et al. Colorectal cancer screening: recommendations for physicians and patients from the U.S. Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2017;153(1):307–323. doi: 10.1053/j.gastro.2017.05.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2017.05.013</ArticleId><ArticleId IdType="pubmed">28600072</ArticleId></ArticleIdList></Reference><Reference><Citation>Deeds SA, Moore CB, Gunnink EJ, et al. Implementation of a mailed faecal immunochemical test programme for colorectal cancer screening among veterans. BMJ Open Qual. 2022;11(4):e001927. doi: 10.1136/bmjoq-2022-001927.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjoq-2022-001927</ArticleId><ArticleId IdType="pmc">PMC9670919</ArticleId><ArticleId IdType="pubmed">36384879</ArticleId></ArticleIdList></Reference><Reference><Citation>Selby K, Jensen CD, Levin TR, et al. Program components and results from an organized colorectal cancer screening program using annual fecal immunochemical testing. Clin Gastroenterol Hepatol. 2022;20(1):145–152. doi: 10.1016/j.cgh.2020.09.042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cgh.2020.09.042</ArticleId><ArticleId IdType="pmc">PMC7526597</ArticleId><ArticleId IdType="pubmed">33010408</ArticleId></ArticleIdList></Reference><Reference><Citation>Deeds S, Liu T, Schuttner L, et al. A postcard primer prior to mailed fecal immunochemical test among veterans: a randomized controlled trial. J Gen Intern Med. 2023;38(14):3235–3241. doi: 10.1007/s11606-023-08248-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-023-08248-7</ArticleId><ArticleId IdType="pmc">PMC10249919</ArticleId><ArticleId IdType="pubmed">37291363</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>